MOLECULAR-DYNAMICS SIMULATION OF HIV-1 PROTEASE IN A CRYSTALLINE ENVIRONMENT AND IN SOLUTION

被引:74
作者
YORK, DM [1 ]
DARDEN, TA [1 ]
PEDERSEN, LG [1 ]
ANDERSON, MW [1 ]
机构
[1] UNIV N CAROLINA,DEPT CHEM,CHAPEL HILL,NC 27599
关键词
D O I
10.1021/bi00057a007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Simulations of the unbound form of the human immunodeficiency virus type 1 protease have been carried out to 200 ps in a crystalline environment and in solution. Solution simulations were performed with and without charge-balancing counterions. The results are compared with the 2.8-angstrom crystallographic structure of Wlodawer et al. [(1989) Science 245, 6161, and a proposed model for the solution structure which involves local refolding of the flap regions is presented. The simulations suggest the crystal packing environment of the protease dimer stabilizes the flaps in an extended conformation. Solvation of the dimer leads to local refolding of the flaps which contract toward the active site, forming increased overlap and stronger intersubunit hydrogn bonding at the tips. The degree to which the flaps overlap in solution is observed to depend on the charge state of the system.
引用
收藏
页码:1443 / 1453
页数:11
相关论文
共 51 条
  • [1] CRYSTAL-STRUCTURE OF INTERLEUKIN-8 - SYMBIOSIS OF NMR AND CRYSTALLOGRAPHY
    BALDWIN, ET
    WEBER, IT
    STCHARLES, R
    XUAN, JC
    APPELLA, E
    YAMADA, M
    MATSUSHIMA, K
    EDWARDS, BFP
    CLORE, GM
    GRONENBORN, AM
    WLODAWER, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (02) : 502 - 506
  • [2] BAX A, 1989, ANNU REV BIOCHEM, V58, P223
  • [3] BLUNDELL TL, 1985, ASPARTIC PROTEINASES, P151
  • [4] X-RAY CRYSTAL-STRUCTURE OF THE HIV PROTEASE COMPLEX WITH L-700,417, AN INHIBITOR WITH PSEUDO C2 SYMMETRY
    BONE, R
    VACCA, JP
    ANDERSON, PS
    HOLLOWAY, MK
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (24) : 9382 - 9384
  • [5] DARKE PL, 1989, J BIOL CHEM, V264, P2307
  • [6] HUMAN IMMUNODEFICIENCY VIRUS PROTEASE EXPRESSED IN ESCHERICHIA-COLI EXHIBITS AUTOPROCESSING AND SPECIFIC MATURATION OF THE GAG PRECURSOR
    DEBOUCK, C
    GORNIAK, JG
    STRICKLER, JE
    MEEK, TD
    METCALF, BW
    ROSENBERG, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (24) : 8903 - 8906
  • [7] THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS
    DEBOUCK, C
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) : 153 - 164
  • [8] DESIGN, ACTIVITY, AND 2.8 A CRYSTAL-STRUCTURE OF A C2 SYMMETRICAL INHIBITOR COMPLEXED TO HIV-1 PROTEASE
    ERICKSON, J
    NEIDHART, DJ
    VANDRIE, J
    KEMPF, DJ
    WANG, XC
    NORBECK, DW
    PLATTNER, JJ
    RITTENHOUSE, JW
    TURON, M
    WIDEBURG, N
    KOHLBRENNER, WE
    SIMMER, R
    HELFRICH, R
    PAUL, DA
    KNIGGE, M
    [J]. SCIENCE, 1990, 249 (4968) : 527 - 533
  • [9] DETERMINATION OF THE RELATIVE BINDING FREE-ENERGIES OF PEPTIDE INHIBITORS TO THE HIV-1 PROTEASE
    FERGUSON, DM
    RADMER, RJ
    KOLLMAN, PA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) : 2654 - 2659
  • [10] FITZGERALD PMD, 1990, J BIOL CHEM, V265, P14209